bioAffinity Technologies (BIAF) Current Leases (2023 - 2026)

bioAffinity Technologies has disclosed Current Leases across 4 years of filings, most recently posting $80241.0 for Q1 2026.

• In Q1 2026, Current Leases fell 38.44% year-over-year to $80241.0; the TTM figure through Mar 2026 stood at $80241.0 (down 38.44% YoY), while the FY2025 annual figure was $139490.0, up 9.41% from the prior year.
• Current Leases declined to $80241.0 in Q1 2026, from $139490.0 in the prior quarter.
• Over the last five years, Current Leases for BIAF reached as high as $387780.0 in Q3 2024 and fell as low as $80241.0 in Q1 2026.
• The 4-year median for Current Leases is $133239.0 (2025), against an average of $187697.0.
• The widest YoY moves for Current Leases: up 34.89% in 2025, down 64.96% in 2025.
• A 4-year view of Current Leases shows it stood at $94708.0 in 2023, then surged by 34.62% to $127498.0 in 2024, then grew by 9.41% to $139490.0 in 2025, then sank by 42.48% to $80241.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $80241.0, $139490.0, and $136197.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.